Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
PR for AfterHours and TUE Nov 07
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by J_U_ICE: [QB] AVVW (.0075) Successfully Expands into Hispanic Market PR Newswire "US Press Releases " LUMBY, British Columbia, Nov. 7 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. (OTCBB: AVVW), a global biotechnology company offering therapeutic, natural skin and health care products, announced today that its expansion into the Hispanic market is experiencing rapid success. Dr. Mario Zamora, director of the Hispanic Health Institute (HHI) and head of avVaa's Houston Pilot Project said, "We are pleased that the Houston Pilot Project is going as well as planned. We are already in 15 OTC stores with sales of over $400 a day. We are starting to distribute products in 100 other stores as of Monday, November 6." Zamora continued, "We are already advertising in a major classifieds publication that reaches a large Hispanic audience in the region, through posters, flyers, and three radio stations. In addition, the Spanish call center is taking daily orders that are expected to increase exponentially as consumers become more familiar with our high quality products." avVaa World Healthcare Chairman and CEO Jack Farley said, "We are extremely grateful to Dr. Zamora for his dedicated support helping us to fulfill crucial health care needs in the Hispanic community. We are thankful that Dr. Zamora has brought the needs of this community to our attention as it is greatly underserved in health care markets, and especially with regard to skin care treatments." avVaa World Health Care Products' Houston Pilot Project is a comprehensive marketing and sales initiative designed to bring avVaa products to the Hispanic community via the Hispanic Health Institute (HHI). Initially, avVaa's unique line of skin care products is being marketed to and sold in and around Houston, Texas. Both avVaa and HHI expect the Houston Pilot Project to eventually lead to strong franchise opportunities within the Hispanic community in Canada, the United States, Mexico and other international markets and to meet the underrepresented health and skin care needs of the Hispanic community at large. About avVaa World Health Care Products avVaa World Health Care Products (OTC-BB: AVVW) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA- Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally. The Company's second generation of its unique, high-quality therapeutic skin care products includes a comprehensive line of Animal Care products designed to capture share of the $44 billion+ worldwide animal care and products market. avVaa sells its quality Animal Care products through partnerships with established distributors in both Canada and the United States. Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward- looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition. For additional information on avVaa, contact Jack Farley CEO / Chairman, at 1-866-772-8822 or visit: [URL=http://www.avvaa.com]www.avvaa.com[/URL] or [URL=http://www.otcfn.com/avvw.]www.otcfn.com/avvw.[/URL] Investor Relations: Merle Goertz (West Coast) of avVaa World Health Care Products, 1-604-688-2349; or Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625. SOURCE avVaa World Health Care Products [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2